WallStreetZenWallStreetZen

NASDAQ: OKUR
Onkure Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Onkure Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, OKUR annual revenue was $0.0, with N/A growth year-over-year.

OKUR revenue history

Current Revenue
$0.0
Current Earnings
-$52.7M
Current Profit Margin
0%

Be the first to know when OKUR announces revenue.

OKUR Revenue History By Year

OKUR Yearly RevenueOKUR RevenueOKUR ChangeOKUR Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A

1 of 1

Onkure Therapeutics Revenue FAQ

What was OKUR's revenue last quarter?

Onkure Therapeutics (NASDAQ: OKUR) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Onkure Therapeutics's revenue was $0.00.

What was Onkure Therapeutics's revenue in 2024?

Onkure Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Onkure Therapeutics make in a day?

Based on Onkure Therapeutics annual revenue for the past five years, OKUR makes an average of $0.00 per day.

What was Onkure Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Onkure Therapeutics's revenue has grown null year over year. Onkure Therapeutics's revenue in the past year totaled $0.00.

How much does Onkure Therapeutics make in a year?

Onkure Therapeutics's revenue by year for the past five years is:
  • Onkure Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Onkure Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Onkure Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Onkure Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Onkure Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.